ZooMAb® antibody

Geplaatst door: Merck

 

Our ZooMAb® recombinant antibodies platform represents an entirely new generation of recombinant monoclonal antibodies that offer the superior specificity and affinity of a monoclonal and polyclonal combined with the flexibility of a recombinant for a wider selection of targets, formats, and species.

Highest reproducibility and performance:

Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Each antibody is validated to reliably perform across multiple applications, including its most commonly used application.